Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Practices of Pancreatic Neck Margin Testing and Their Outcomes after Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma.

Annals of surgical oncology·2026
Same author

Defining the Incremental Value of Endoscopic Ultrasound in Assessing Pancreatic Cystic Neoplasms.

Annals of surgery·2026
Same author

Robotic recipient liver transplantation worldwide: a systematic review and meta-analysis of the first 93 patients, from feasibility to early outcomes.

EClinicalMedicine·2026
Same author

Reply to Dion et al. Comment on "Sun et al. First Experience with Hypothermic Oxygenated Perfusion in Human Uteri: Feasibility and Metabolic Characterization. <i>J. Clin. Med.</i> 2026, <i>15</i>, 2820".

Journal of clinical medicine·2026
Same author

Cost-Effectiveness of Pharmacologic Therapies for Metabolic Dysfunction-Associated Steatohepatitis With Significant Fibrosis in the United States.

Diabetes, obesity & metabolism·2026
Same author

Donor obesity and MASLD as barriers to living donor liver transplantation: Institutional attrition and national outcomes.

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2026
Same journal

Integrated Genomic, Transcriptomic, and Circulating Biomarkers Predict Benefit to Immune Checkpoint Inhibitor Plus Chemotherapy in Advanced Non-Small Cell Lung Cancer.

MedComm·2026
Same journal

Current Landscape and Future Perspectives of Diabetic Retinopathy Therapy: Pharmacological Targets, Precision Laser Technology, and Clinical Evidence.

MedComm·2026
Same journal

The Multifaceted Role of Pyroptosis: Molecular Mechanisms, Crosstalk with Other Cell Death Pathways, and Therapeutic Implications.

MedComm·2026
Same journal

Melanosomes as Antigen-Presenting Decoys in Melanoma Immune Evasion.

MedComm·2026
Same journal

Development and Validation of a Pathomics Model for Prognosis Prediction in Neoadjuvant Therapy-Treated Breast Cancer: A Retrospective, Multicenter Study.

MedComm·2026
Same journal

Cancer Heterogeneity and Cancer Cell Plasticity: Molecular Mechanisms and Precision Therapy.

MedComm·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.6K

Mastering Organoid Growth: A Complete Guide to Overcoming Methodological Challenges.

Chunbao Jiao1,2, Omer Faruk Karakaya1, Neda Dadgar3

  • 1Department of Inflammation and Immunity Cleveland Clinic Research Cleveland Clinic Cleveland Ohio USA.

Medcomm
|January 8, 2026
PubMed
Summary
This summary is machine-generated.

This review details organoid cultivation methods, focusing on liver, gut, kidney, and pancreas organoids. It addresses challenges and innovations for improved reproducibility and clinical translation in organoid research.

Keywords:
cholangiocytemethodologyorganoidorganoid applications

More Related Videos

Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs
06:38

Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs

Published on: March 15, 2024

2.1K
Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture
07:11

Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture

Published on: August 25, 2022

3.9K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.6K
Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs
06:38

Author Spotlight: Advancing Organoid Generation for Drug Development Using iPSCs

Published on: March 15, 2024

2.1K
Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture
07:11

Maintaining Human Glioblastoma Cellular Diversity Ex vivo using Three-Dimensional Organoid Culture

Published on: August 25, 2022

3.9K

Area of Science:

  • Biotechnology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Organoid technology offers 3D, physiologically relevant models of human organs.
  • Recent advancements have increased organoid popularity for research applications.

Purpose of the Study:

  • To provide an updated, in-depth review of organoid cultivation methodologies.
  • To explore current technological challenges and emerging innovations in organoid research.
  • To guide researchers in improving reproducibility and expanding organoid applications.

Main Methods:

  • Review of current literature on organoid cultivation techniques.
  • Analysis of challenges in nutrient delivery, cellular diversity, scalability, and high-throughput applications.
  • Discussion of bioengineering, microfluidics, and genetic manipulation for organoid advancement.

Main Results:

  • Detailed methodologies for efficient organoid cultivation are presented.
  • Key challenges in organoid culture, including optimization and scalability, are identified.
  • Emerging innovations and their potential impact on disease modeling and personalized medicine are discussed.

Conclusions:

  • Standardized protocols and practical insights are provided to enhance organoid research reproducibility.
  • Barriers to clinical translation are addressed, highlighting knowledge gaps.
  • Future perspectives on next-generation technologies for organoid development are outlined.